|
|
|
|
|
|
  |
|
IOM honors two from Yale The Institute of Medicine has honored two from Yale with senior membership. Pasko Rakic, M.D., Sc.D., the Dorys McConnell Duberg Professor of Neuroscience and chair of the Section of Neurobiology, and Lewis P. Rowland, M.D. ’48, HS ’50, professor of neurology at Columbia University in New York, were elected to the senior ranks in October. Among the 55 new members of the institute were four Yale alumni, including Yale College graduates David Ginsburg, M.D., Richard Hodes, M.D., and Jeffrey P. Koplan, M.D., M.P.H.; and Nancy Hopkins, Ph.D., a biologist who did her graduate work at Yale. |
|
|
|
After almost 70 years, the Yale Psychiatric Institute is closing its doors, a victim of the new economics of health care. YPI’s functions will transfer from the School of Medicine to Yale-New Haven Hospital as soon as the change is approved by the state’s Office of Health Care Access. William H. Sledge, M.D., assistant chief of psychiatry at the hospital, will be medical director of the new facility, which will be known as the Yale-New Haven Psychiatric Hospital and will occupy the same Frank Gehry-designed building on the corner of Cedar Street and Congress Avenue. Sledge said three factors led to the decision to close YPI. Yale-New Haven Hospital has more access to patients through its medical services and can participate in federal programs such as Medicare and Medicaid more fully than a free-standing psychiatric hospital. "The other part of it is that it is very inefficient to have two psychiatric services operating side by side and duplicating a lot of the overhead and other support services," Sledge said. And, he added, a free-standing psychiatric institute lacks the negotiating clout of a hospital that’s part of a larger health care system. |
||
|
|
The Office of Cooperative Research has struck a deal with a Science Park biotech firm to distribute new reagents created during the course of University research. Recombinant Technologies, founded by associate research scientist Pazhani Sundaram, Ph.D., of the School of Public Health, will work with the University to identify commercially viable reagents and negotiate their distribution to researchers. |
||
|
|
Connecticut’s
Supreme Court has thrown out a $12.2 million award to a former
hospital intern who was infected with HIV after an accidental
needle prick. In dismissing the damage award, the court also
ordered a new trial in the case. The intern, known in court papers
as Dr. Doe, sued the University and Yale-New Haven Hospital and
claimed that the incident was the result of inadequate training
and supervision. She pricked herself in 1988 while inserting
a line into a patient with AIDS. |
||
|
|
A Yale chemistry professor is looking at natural products from a Western Pacific marine sponge as a potential source of chemotherapeutic agents. David J. Austin, Ph.D., has received a three-year, $150,000 grant from the Johnson & Johnson Focused Giving Program, which funds health care and medical research by academic scientists. Austin plans to use the grant to synthesize palau’mine, a sponge found off the Palau Islands, and evaluate its biological effects. |
||
|
|
Connecticut’s best-known meteorologist is donating the proceeds from his best-selling book, The Complete Idiot’s Guide to the Weather, to the Yale Cancer Center. Dr. Mel Goldstein was diagnosed three years ago with a rare cancer of the bone marrow and credits his care at the cancer center with keeping him alive since then. His treatment has included a combination therapy using thalidomide, the compound that caused birth defects when used by pregnant women in the early 1960s, but which recently has shown promise as a cancer drug. Proceeds from the book will benefit the Dr. Mel Goldstein Multiple Myeloma Research Fund. |
||
|
|
The Center for Medical Informatics plans to use a $1.5 million grant it was awarded last year to develop a computer system to analyze and compare tumor cells. The grant from the National Library of Medicine will allow researchers to test the Next Generation Internet using PathMaster, a software being developed at Yale to analyze cell images. Lymphoma and thyroid cells will be studied. As part of the project, the center will expand its database of malignant-cell images from 500 to 30,000 over the next three years, according to Director Perry L. Miller, M.D., Ph.D. |
|
|
IOM
honors two from Yale | Farewell to YPI | A
spinoff from the lab | Dr.
Doe decision is reversed | Bring
in the marine sponges | Dr.
Mel’s doctors | Informatics
initiative
|
